2.7. ScFv PD-L1 Antibody Promotes Anti-Tumor Efficacy and Attenuates Exhaustion of CAR T Cells in HCC1954 Breast Cancer Xenograft Tumors In Vivo. This evidence concerns the gene CD274 and breast carcinoma.